Jul 11, 2023, 18:24
Dangerous & wrong narrative being promulgated by ISPOR – Richard Sullivan
Dangerous & wrong narrative being promulgated by ISPOR “Continued reliance on .. OS benefit as the primary measure of innovation in oncology ….restrict(s) patient access to innovative therapies & leads to higher healthcare costs”.
For details: Click here
Source: Richard Sullivan/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 14:06
Dec 21, 2024, 13:46
Dec 21, 2024, 13:40
Dec 21, 2024, 13:33
Dec 21, 2024, 13:20